This contrasts with the results from the same experiment performed in immunocompetent mice (figure 1A), suggesting that the adaptive immune system is necessary for tumor-promoting, host-mediated effects induced by anti-PD1 treatment. This evidence concerns the gene PDCD1 and neoplasm.